Aethlon Medical (AEMD) Return on Capital Employed (2011 - 2026)
Aethlon Medical's (AEMD) quarterly Return on Capital Employed came in at 126.88% in Q1 2026, up 5835.0% YoY from 2.14% in Q1 2025, and down 10.78% on a QoQ basis from 114.54% in Q4 2025.
Aethlon Medical (AEMD) Return on Capital Employed (2011 - 2026) Analysis & Trends
Aethlon Medical (AEMD) has 16 years of Return on Capital Employed data on file, last reported at 126.88% in Q1 2026.
- Quarterly Return on Capital Employed rose 5835.0% year-over-year to 126.88% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 126.88% (up 5835.0% YoY) and the FY2026 annual result came in at 135.08%, up 2315.0% from the prior year.
- Return on Capital Employed fell to 126.88% in Q1 2026, from 114.54% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 55.3% in Q1 2022 to a low of 185.23% in Q1 2025.
- A 5-year average of 119.4% and a median of 126.88% in 2026 frame the typical range for Return on Capital Employed.
- Annual changes were most pronounced in 2024 — Return on Capital Employed sank 10067 bps — and 2026, when it jumped 5835 bps.
- Tracing AEMD's Return on Capital Employed over 5 years: stood at 67.9% in 2022, then slumped by 95 bps to 132.49% in 2023, then retreated by 25 bps to 166.15% in 2024, then jumped by 31 bps to 114.54% in 2025, then decreased by 11 bps to 126.88% in 2026.
- The last three Return on Capital Employed figures came in at 126.88% (Q1 2026), 114.54% (Q4 2025), and 145.04% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.62 Bn | 197.02 Bn | 7.27 Bn | 7.98% |
| 2 | Stryker | 127.01 Bn | 123.54 Bn | 4.50 Bn | 13.69% |
| 3 | Medtronic | 119.39 Bn | 110.17 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 74.56 Bn | 74.02 Bn | 3.85 Bn | 10.83% |
| 5 | Edwards Lifesciences | 51.82 Bn | 47.57 Bn | 1.35 Bn | 11.99% |
| 6 | Dexcom | 34.98 Bn | 33.03 Bn | 830.00 Mn | 27.21% |
| 7 | GE HealthCare Technologies | 33.85 Bn | 31.74 Bn | 2.18 Bn | 9.47% |
| 8 | Koninklijke Philips | 26.26 Bn | 22.94 Bn | 4.55 Bn | 12.84% |
| 9 | Steris | 23.23 Bn | 22.75 Bn | 684.20 Mn | 12.08% |
| 10 | Aethlon Medical | 1.07 Mn | 1.07 Mn | - | -134.91% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -134.91% |
| Mar 31, 2026 | -126.88% |
| Dec 31, 2025 | -114.54% |
| Sep 30, 2025 | -145.04% |
| Jun 30, 2025 | -180.93% |
| Mar 31, 2025 | -185.23% |
| Dec 31, 2024 | -166.15% |
| Sep 30, 2024 | -148.41% |
| Jun 30, 2024 | -153.85% |
| Mar 31, 2024 | -168.23% |
| Dec 31, 2023 | -132.49% |
| Sep 30, 2023 | -94.50% |
| Jun 30, 2023 | -83.60% |
| Mar 31, 2023 | -67.56% |
| Dec 31, 2022 | -67.90% |
| Sep 30, 2022 | -71.63% |
| Jun 30, 2022 | -67.52% |
| Mar 31, 2022 | -55.30% |
| Dec 31, 2021 | -40.78% |
| Sep 30, 2021 | -36.89% |